GAMP Services IPO — DRHP Details, Business & Financials
About GAMP Services
GAMP Services Limited is a Vadodara-based compliance and validation company offering validation, qualification, and instrumentation solutions primarily to regulated industries. Incorporated in 2020, the company acquired the business of the partnership firm M/s. Gamp Services as a going concern effective March 31, 2026. The company operates across three verticals: services, distribution as an authorized channel partner for global OEMs, and data logger manufacturing (commenced in Fiscal 2027). In Fiscal 2026, it served 286 customers across 21 Indian states and 10 countries, generating Rs 4,581.37 lakhs in revenue from operations.
Business Model
The company operates a B2B model delivering validation services, clean room validation, thermal validation, and computer system validation, alongside distributing specialized instrumentation from global OEMs and manufacturing data loggers. Revenue is primarily earned from service fees and product sales to clients in the life sciences sector (pharmaceuticals, medical devices, food and beverage) as well as high-tech industries including aerospace, electronics, and electric vehicles.
Financial Performance
| Metric | As at and for the three months ended June 30, 2026 | Fiscal 2026 | Fiscal 2025 | Fiscal 2024 |
|---|---|---|---|---|
| Revenue from operations | 1,945.85 | 4,581.37 | 3,569.46 | 1,909.38 |
| Total income | 1,955.50 | 4,605.37 | 3,584.77 | 1,915.03 |
| EBITDA | 795.88 | 1,518.35 | 1,123.49 | 441.91 |
| EBITDA Margin | 40.90% | 33.14% | 31.48% | 23.14% |
| Profit after Tax for the period/ year | 580.76 | 1,096.77 | 795.29 | 304.47 |
| PAT Margin | 29.85% | 23.94% | 22.28% | 15.95% |
| Net worth | 3,781.89 | 2,993.22 | 1,129.08 | 336.89 |
| Total borrowings | 18.53 | 24.70 | 51.54 | 78.64 |
| Return on Net Worth | 17.14% | 53.21% | 108.50% | 80.76% |
| Basic EPS (₹ per share) | 4.86 | 10.45 | 8.66 | 4.80 |
| Debt-equity ratio | 0.01 | 0.01 | 0.04 | 0.15 |
All figures Rs in lakhs (except EPS, Debt-equity ratio, and margins) unless otherwise stated.
Figures as disclosed in the DRHP filed with SEBI. Source: offer document.
Objects of the Issue
- Funding capital expenditure towards purchase of equipment and IT hardware for Services and Data Logger Manufacturing verticals amounting to Rs 4,005.34 lakhs.
- Funding inorganic growth through unidentified acquisitions and general corporate purposes (amount not disclosed in excerpts).
Promoters
The promoters are Sanjeevkumar Mahendrakumar Patel, Girish Agrawal, and Gaurav M Shah, holding an aggregate of 99.99% of the pre-Offer paid-up equity share capital. Patel and Agrawal possess over 26 years of experience each in instrumentation and validation, while Shah brings over 19 years of commercial and client relationship experience.
Strengths
- Experienced leadership and skilled workforce with deep technical and validation expertise.
- Diversified, long-standing customer relationships complemented by partnerships with marquee global OEMs.
- Comprehensive and integrated portfolio of compliance, qualification, and validation services.
- Track record of continuous growth in financial performance backed by low debt levels.
Key Risks
- High sector concentration, with life sciences and pharmaceuticals contributing 87.39% of Fiscal 2026 revenue.
- High dependence on foreign suppliers, who accounted for 87.82% of total purchases in Fiscal 2026.
- Top ten customers accounted for 42.00% of revenue from operations in Fiscal 2026.
- Geographic concentration with Gujarat and Telangana generating 41.17% of Fiscal 2026 revenue.
- The planned Rs 4,005.34 lakhs capital expenditure is entirely uncommitted without purchase orders, and acquisition targets remain unidentified.
Points to Weigh
- Demonstrated strong revenue and profit growth with EBITDA margins expanding from 23.14% in FY24 to 33.14% in FY26.
- Maintains a minimal debt burden, with a debt-equity ratio of 0.01 as of Fiscal 2026.
- Revenues remain heavily reliant on the pharmaceutical industry and top ten customers.
- Inorganic growth funds and major equipment capex plans are currently uncommitted to specific targets or suppliers.